Paul Langlie Martin

Professor Emeritus of Pediatrics

Pediatrics, Transplant and Cellular Therapy

paul.martin@duke.edu

Box 102502 Med Ctr, Durham, NC 27710

2400 Pratt St, North Pavilion; Room 8045, Durham, NC 27705

More About This Person

At a Glance

Credentials
1. Education
2. Licensure

Academic Experience

Expertise

Research
1. Selected Grants

Publications
1. Selected Publications

Artistic Works / Events

Teaching
1. Recent Courses

Advising & Mentoring

Recognition

Professional Activities
1. Clinical Activities

Embed Profile Data

Embed Profile Data

Selected Grants

PHASE 3 STUDY EVALUATING GENE THERAPY BY TRANSPLANTATION OF AUTOLOGOUS CD34+ STEM CELLS TRANSDUCED EX VIVO WITH THE LENTIGLOBIN BB305 LENTIVIRAL VECTOR IN SUBJECTS WITH SEVERE SICKLE CELL DISEASE

Clinical TrialPrincipal Investigator · Awarded by Bluebird Bio · 2020 - 2026

A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT)

Clinical TrialPrincipal Investigator · Awarded by National Marrow Donor Program · 2023 - 2025

STELLAR Study

Clinical TrialPrincipal Investigator · Awarded by Children's Healthcare of Atlanta · 2019 - 2022

A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia

Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2015 - 2022

A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant

Clinical TrialPrincipal Investigator · Awarded by Jazz Pharmaceuticals · 2017 - 2021

PBMTC SUP 1601 Pathogen Identification in Pediatric HSCT

ResearchPrincipal Investigator · Awarded by Children's Hospital Los Angeles · 2016 - 2021

A Phase 2 Multicenter Single arm Study of Moxetumomab Pasudotox in Pediatric Subjects with Relapsed or Refractory pALL

Clinical TrialPrincipal Investigator · Awarded by MedImmune, Inc. · 2014 - 2016

Pediatric Oncology Group (POG)

ResearchInvestigator · Awarded by National Institutes of Health · 1983 - 2002